Table 2.
Group | Additional Anxiety and/or Depressive Symptoms | Current Psychiatric Medication | Current or Past Psychotherapy |
---|---|---|---|
Tapping | 78% 1 | 67% | 67% |
PMR (control) | 85% 2 | 62% | 85% |
1 45% of the Tapping group experienced additional anxiety symptoms to main diagnosis; 44% depressive symptoms, 11% somatoform symptoms. 2 PMR group: 69% additional anxiety symptoms to main diagnosis; 38% depressive symptoms, 8% somatoform symptoms, 8% subclinical eating disorder (related to anxiety).